Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Paola Barbarino, CEO, Alzheimer’s Disease International, shares her perspective on what is to come in the Alzheimer’s disease space, particularly the impact of COVID-19 on the diagnosis of dementia and disruption in clinical trials. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.